USD 2.15
(0.93%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 CNY | 100.0% |
2022 | -192.85 Million CNY | -206.27% |
2021 | 181.46 Million CNY | -44.03% |
2020 | 324.21 Million CNY | 103.07% |
2019 | 159.65 Million CNY | -2.2% |
2018 | 163.24 Million CNY | 297.66% |
2017 | 41.05 Million CNY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | -2.45 Million CNY | -100.0% |
2024 Q1 | 1.00 CNY | 0.0% |
2023 Q4 | 1.00 CNY | 100.0% |
2023 Q3 | -97.9 Million CNY | -9790300100.0% |
2023 FY | 1.00 CNY | 100.0% |
2023 Q1 | 1.00 CNY | 100.0% |
2023 Q2 | 1.00 CNY | 0.0% |
2022 Q1 | -96.18 Million CNY | -153.0% |
2022 Q4 | -192.85 Million CNY | -108.14% |
2022 Q3 | -92.65 Million CNY | 8.65% |
2022 FY | -192.85 Million CNY | -206.27% |
2022 Q2 | -101.43 Million CNY | -5.46% |
2021 Q2 | -69.06 Million CNY | -3.15% |
2021 FY | 181.46 Million CNY | -44.03% |
2021 Q1 | -66.95 Million CNY | -120.65% |
2021 Q4 | 181.46 Million CNY | 367.99% |
2021 Q3 | -67.71 Million CNY | 1.95% |
2020 Q4 | 324.21 Million CNY | 927.88% |
2020 Q1 | -32.46 Million CNY | -120.34% |
2020 Q3 | -39.16 Million CNY | -14.43% |
2020 Q2 | -34.22 Million CNY | -5.41% |
2020 FY | 324.21 Million CNY | 103.07% |
2019 Q4 | 159.65 Million CNY | -31.57% |
2019 Q2 | 152.34 Million CNY | 0.0% |
2019 Q1 | - CNY | -100.0% |
2019 FY | 159.65 Million CNY | -2.2% |
2019 Q3 | 233.3 Million CNY | 53.14% |
2018 FY | 163.24 Million CNY | 297.66% |
2018 Q1 | - CNY | 0.0% |
2018 Q4 | 163.24 Million CNY | 0.0% |
2017 FY | 41.05 Million CNY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
CorVel Corporation | - USD | -Infinity% |
eHealth, Inc. | 1.00 USD | 0.0% |
Erie Indemnity Company | 1.00 USD | 0.0% |
GoHealth, Inc. | - USD | -Infinity% |
Reliance Global Group, Inc. | 1.00 USD | 0.0% |
Reliance Global Group, Inc. | 1.00 USD | 0.0% |
Tian Ruixiang Holdings Ltd | - USD | -Infinity% |
Willis Towers Watson Public Limited Company | - USD | -Infinity% |